Eisai Oncology Medical’s Post

Join PeerView Live, GRASP, and Living Beyond Breast Cancer for a “Candid Conversations & Clinical Consults” educational activity, where expert panelists provide guidance on navigating the most recent evidence and evolving best practice recommendations for risk assessment, predictive/prognostic testing, and selection and sequencing of therapies in HR+ EBC and MBC. Learn more: https://bit.ly/3VLTq37 #MedEd #Oncology #ASCO2024

Discover the latest advancements in PARP with our updated pipeline, now available as a downloadable PDF. Stay on top of the latest in cancer research and innovation with LARVOL. Learn more: https://bit.ly/3L20ORN #LARVOL #PARP #Oncology #CancerResearch #MedicalProgress #OncologyUpdates #CancerCare

The field of immuno-oncology has a transformative impact, across different cancer types, with many advancements made in recent years. With the potential to treat many patients who need it most, it is important to know the current trends in the immunooncology clinical trial space. Download our free white paper, authored by Graham Belgrave, to learn more: https://hubs.la/Q02lJnDV0 #immunooncology #oncology #clinicaltrials #clinicalresearch

This recent survey on breast cancer patient experience by Loxo@Lilly, Ipsos, and Living Beyond Breast Cancer struck a chord with me having watched my own mother during her cancer treatment. The authors discuss the concept of “time toxicity” - the significant time spent on treatments, travel, and recovery and how this total experience affects their personal lives. Time toxicity significantly impacts even retired patients like my mom, yet younger women with careers and young children also find themselves having to navigate these exhausting treatment schedules. One aspect of the care journey that can be improved is increasing the availability of IV to oral-conversion options for oncology patients. Advanced formulation and manufacturing technologies, like AustinPx’s KinetiSol™ Technology, can help overcome solubility and permeability boundaries to drive IV to oral-conversion and improve patient experience. To my industry colleagues, how is your organization approaching improving patient experience for oncology treatments? #Pharma #CDMO #Oncology #PatientExperience

Learn the key oncology abstracts and datasets to watch out for at ASCO 2024, the world's largest cancer conference. Join our webinar on May 28 for insights from Bloomberg Intelligence analysts. Register here: https://bloom.bg/4alh0Yz #corporations #oncology #data #ASCO24

The field of immuno-oncology has a transformative impact, across different cancer types, with many advancements made in recent years. With the potential to treat many patients who need it most, it is important to know the current trends in the immunooncology clinical trial space. Download our free white paper, authored by Graham Belgrave, to learn more: https://hubs.la/Q02PYGjV0 #Immunooncology #Oncology #ClinicalTrials #ClinicalResearch

The high unmet medical need for early onset cancer has implications for the regulatory pathway and the perceived value of newly developed agents. Learn the nuanced considerations for developing and marketing a new treatment for cancer in younger adults in our upcoming webinar: https://ow.ly/hOzq50Qk9Er #earlyonsetcancer #oncology #drugdevelopment

Did you know that there are over 100 different types of cancer, each with unique challenges and treatment approaches? At #ESMO2024, I’m eager to explore the latest research and innovations that can help us address these challenges. Looking forward to attending #ESMO24 and meeting you there! #Oncology #MedicalEducation #drugdevelopment #MedicalAffairs #RocheOncology

The high unmet medical need for early onset cancer has implications for the regulatory pathway and the perceived value of newly developed agents. Learn the nuanced considerations for developing and marketing a new treatment for cancer in younger adults in our upcoming webinar: https://ow.ly/hOzq50Qk9Er #earlyonsetcancer #oncology #drugdevelopment

Learn the key oncology abstracts and datasets to watch out for at ASCO 2024, the world's largest cancer conference. Join our webinar on May 28 for insights from Bloomberg Intelligence analysts. Register here: https://bloom.bg/4dKLNRu #corporations #oncology #data #ASCO24